Pyroptosis in combinatorial treatment to improve cancer patients' outcome, is that what we want?
作者信息
Pezuk Julia Alejandra
机构信息
Programa de Mestrado Profissional em Farmácia, Programa de Pós-graduação em Biotecnologia e Inovação em Saúde, Programa de Pós-graduação em Ensino de Ciências e Saúde, Universidade Anhanguera de São Paulo (UNIAN/SP), São Paulo, Brazil.
出版信息
EBioMedicine. 2019 Mar;41:17-18. doi: 10.1016/j.ebiom.2019.03.007. Epub 2019 Mar 14.
Abstract
摘要
相似文献
1
Pyroptosis in combinatorial treatment to improve cancer patients' outcome, is that what we want?联合治疗中的细胞焦亡以改善癌症患者的预后，这是我们想要的吗？
EBioMedicine. 2019 Mar;41:17-18. doi: 10.1016/j.ebiom.2019.03.007. Epub 2019 Mar 14.
2
Chemotherapy drugs induce pyroptosis through caspase-3-dependent cleavage of GSDME.化疗药物通过半胱天冬酶-3依赖性切割GSDME诱导细胞焦亡。
Sci China Life Sci. 2018 Jun;61(6):739-740. doi: 10.1007/s11427-017-9158-x. Epub 2018 Feb 28.
3
Design, synthesis, and evaluation of chalcone analogues incorporate α,β-Unsaturated ketone functionality as anti-lung cancer agents via evoking ROS to induce pyroptosis.设计、合成和评价查尔酮类似物，将α,β-不饱和酮官能团作为诱导 ROS 产生细胞焦亡的抗肺癌剂。
Eur J Med Chem. 2018 Sep 5;157:1395-1405. doi: 10.1016/j.ejmech.2018.08.072. Epub 2018 Aug 30.
4
[Resistance to cytostatic drugs].[对细胞生长抑制剂的耐药性]
Duodecim. 1998;114(13):1319-28.
5
Tumor chemosensitization by physical exercise? Insights from an anidmal model.体育锻炼对肿瘤化疗的增敏作用？来自动物模型的见解。
Future Oncol. 2015;11(6):885-7. doi: 10.2217/fon.14.311.
6
Defeating drug resistance in cancer.战胜癌症中的耐药性。
Discov Med. 2006 Feb;6(31):18-23.
7
Cancer drug resistance: old concept, novel solutions required.癌症耐药性：旧概念，需要新解决方案。
Mol Oncol. 2014 Sep 12;8(6):1064-6. doi: 10.1016/j.molonc.2014.07.026. Epub 2014 Aug 7.
8
Pseudoalteromonas haloplanktis TAC125 produces 4-hydroxybenzoic acid that induces pyroptosis in human A459 lung adenocarcinoma cells.海栖假交替单胞菌 TAC125 产生 4-羟基苯甲酸，诱导人 A459 肺腺癌细胞发生细胞焦亡。
Sci Rep. 2018 Jan 19;8(1):1190. doi: 10.1038/s41598-018-19536-2.
9
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.靶向上皮-间质转化（EMT）以克服癌症中的耐药性
Molecules. 2016 Jul 22;21(7):965. doi: 10.3390/molecules21070965.
10
Dodging a dogma: is treating beyond progression beneficial?避开一种教条：疾病进展后继续治疗是否有益？
Cancer Chemother Pharmacol. 2013 May;71(5):1385-6. doi: 10.1007/s00280-013-2123-z. Epub 2013 Feb 27.
引用本文的文献
1
Discovery of indole analogue Tc3 as a potent pyroptosis inducer and identification of its combination strategy against hepatic carcinoma.吲哚类似物Tc3作为一种有效的细胞焦亡诱导剂的发现及其抗肝癌联合策略的鉴定。
Theranostics. 2025 Jan 1;15(4):1285-1303. doi: 10.7150/thno.102228. eCollection 2025.
2
Synergistically Augmenting Cancer Immunotherapy by Physical Manipulation of Pyroptosis Induction.通过物理调控焦亡诱导协同增强癌症免疫治疗
Phenomics. 2024 Jun 22;4(3):298-312. doi: 10.1007/s43657-023-00140-y. eCollection 2024 Jun.
3
Penehyclidine hydrochloride alleviates lung ischemia-reperfusion injury by inhibiting pyroptosis.盐酸戊乙奎醚通过抑制细胞焦亡减轻肺缺血再灌注损伤。
BMC Pulm Med. 2024 Apr 26;24(1):207. doi: 10.1186/s12890-024-03018-5.
4
Quercetin-induced pyroptosis in colon cancer through NEK7-mediated NLRP3 inflammasome-GSDMD signaling pathway activation.槲皮素通过NEK7介导的NLRP3炎性小体-GSDMD信号通路激活诱导结肠癌细胞焦亡。
Am J Cancer Res. 2024 Mar 15;14(3):934-958. doi: 10.62347/MKAN3550. eCollection 2024.
5
The Role of Pyroptosis in the Pathogenesis of Kidney Diseases.细胞焦亡在肾脏疾病发病机制中的作用
Kidney Dis (Basel). 2023 Jun 24;9(6):443-458. doi: 10.1159/000531642. eCollection 2023 Dec.
6
ATOH8 promotes HBV immune tolerance by inhibiting the pyroptotic pathway in hepatocytes.ATOH8 通过抑制肝细胞中的细胞焦亡途径促进 HBV 免疫耐受。
Mol Med Rep. 2023 Jul;28(1). doi: 10.3892/mmr.2023.13018. Epub 2023 May 26.
7
LINC00511/hsa-miR-573 axis-mediated high expression of Gasdermin C associates with dismal prognosis and tumor immune infiltration of breast cancer.LINC00511/hsa-miR-573 轴介导的 Gasdermin C 高表达与乳腺癌的不良预后和肿瘤免疫浸润有关。
Sci Rep. 2022 Aug 30;12(1):14788. doi: 10.1038/s41598-022-19247-9.
8
A Predictive Model Based on Pyroptosis-Related Gene Features Can Effectively Predict Clear Cell Renal Cell Carcinoma Prognosis and May Be an Underlying Target for Immunotherapy.基于细胞焦亡相关基因特征的预测模型可有效预测肾透明细胞癌预后，且可能成为免疫治疗的潜在靶点。
Dis Markers. 2022 Jul 8;2022:6402599. doi: 10.1155/2022/6402599. eCollection 2022.
9
A Comparative Review of Pyroptosis in Mammals and Fish.哺乳动物和鱼类细胞焦亡的比较综述
J Inflamm Res. 2022 Apr 11;15:2323-2331. doi: 10.2147/JIR.S361266. eCollection 2022.
10
A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.一个与细胞焦亡相关的基因特征可预测肝癌患者的预后和免疫图谱。
Comput Math Methods Med. 2022 Feb 16;2022:1258480. doi: 10.1155/2022/1258480. eCollection 2022.
本文引用的文献
1
A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma.PLK1 激酶抑制剂通过诱导食管鳞癌细胞发生细胞焦亡增强顺铂的化疗敏感性。
EBioMedicine. 2019 Mar;41:244-255. doi: 10.1016/j.ebiom.2019.02.012. Epub 2019 Mar 12.
2
BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.BI2536 是一种有效的、选择性的 Polo 样激酶 1 抑制剂，与顺铂联合使用对胃癌细胞具有协同作用。
Int J Oncol. 2018 Mar;52(3):804-814. doi: 10.3892/ijo.2018.4255. Epub 2018 Jan 25.
3
Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling.应用基于生理学的药代动力学模型预测药物-药物相互作用的潜力。
Arch Pharm Res. 2017 Dec;40(12):1356-1379. doi: 10.1007/s12272-017-0976-0. Epub 2017 Oct 27.
4
SynergyFinder: a web application for analyzing drug combination dose-response matrix data.协同作用发现者：一个用于分析药物组合剂量反应矩阵数据的网络应用程序。
Bioinformatics. 2017 Aug 1;33(15):2413-2415. doi: 10.1093/bioinformatics/btx162.
5
Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells.波罗样激酶1的药理抑制作为单一疗法或联合疗法：波罗样激酶1抑制在髓母细胞瘤细胞中的比较效果
Anticancer Agents Med Chem. 2017;17(9):1278-1291. doi: 10.2174/1871520617666170213112904.
6
PLK-1: Angel or devil for cell cycle progression.PLK-1：细胞周期进程中的天使还是魔鬼。
Biochim Biophys Acta. 2016 Apr;1865(2):190-203. doi: 10.1016/j.bbcan.2016.02.003. Epub 2016 Feb 18.
7
Evaluation of Polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma.评估Polo样激酶1作为默克尔细胞癌潜在治疗靶点的作用。
Head Neck. 2016 Apr;38 Suppl 1:E1918-25. doi: 10.1002/hed.24349. Epub 2015 Dec 29.
8
Cancer-related inflammation and treatment effectiveness.癌症相关炎症与治疗效果。
Lancet Oncol. 2014 Oct;15(11):e493-503. doi: 10.1016/S1470-2045(14)70263-3.
9
In vitro targeting of Polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors.在膀胱癌中靶向 Polo 样激酶 1 的体外研究：四种有效抑制剂的比较作用。
Cancer Biol Ther. 2013 Jul;14(7):648-57. doi: 10.4161/cbt.25087. Epub 2013 May 31.
10
Pyroptosis: host cell death and inflammation.细胞焦亡：宿主细胞死亡与炎症反应
Nat Rev Microbiol. 2009 Feb;7(2):99-109. doi: 10.1038/nrmicro2070.
Zotero 插件